Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-11

Clinical Trial Update: Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction. [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluates whether hydration can prevent contrast-induced nephropathy during percutaneous intervention for ST-elevation myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Azienda USL Reggio Emilia - IRCCS | Conditions: Contrast Induced Nephropathy | Phase 4 | Status: COMPLETED